EPICARDIAL FAT

Clinical trials for EPICARDIAL FAT explained in plain language.

Never miss a new study

Get alerted when new EPICARDIAL FAT trials appear

Sign up with your email to follow new studies for EPICARDIAL FAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can diabetes drugs shrink dangerous heart fat to prevent future attacks?

Disease control Recruiting now

This study is testing if two common diabetes drugs, dapagliflozin and semaglutide, can reduce a specific type of fat around the heart (epicardial fat) in people who have just had a serious heart attack. Researchers believe lowering this fat may help prevent future heart problems.…

Matched conditions: EPICARDIAL FAT

Phase: PHASE3 • Sponsor: Instituto Mexicano del Seguro Social • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

EPICARDIAL FAT

Get alerted when new EPICARDIAL FAT trials appear

Can diabetes drugs shrink dangerous heart fat to prevent future attacks?